About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Suven Life Sciences Ltd.
Industry :
Pharmaceuticals & Drugs
BSE Code
530239
ISIN Demat
INE495B01038
Book Value
47.01
NSE Code
SUVEN
Dividend Yield %
0.00
Market Cap
35042.40
P/E
0.00
EPS
-2.57
Face Value
1
BSE
NSE
14-Jan-2026
BSE
NSE
NSE F & O
14-Jan-2026
BSE
NSE
NSE F & O
Last Price
154.05
Net Change
0.55
% Change
0.36%
Prev.Close
153.50
Open
155.05
High
156.25
Low
150.00
Volume
27411
Last Price
154.49
Net Change
1.37
% Change
0.89%
Prev.Close
153.12
Open
156.00
High
156.00
Low
150.50
Volume
340092
Value
4190729
Best Buy
0.00
Best Sell
0.00
Best Quantity
0
Sell Quantity
0
Today's Range
156.25
52-Week High
303.00
52-Week Low
102.70
Value
52082514.41
Best Buy
0.00
Best Sell
154.49
Best Quantity
0
Sell Quantity
1
Today's Range
156.00
52-Week High
299.99
52-Week Low
102.50
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
1
Price
154.49
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Bonus
1 : 1
23-Mar-07
Book Closure
31-Jul-24
02-Aug-24
Rights
1 : 2
18-Oct-22
Dividend
150 %
15-Feb-19
Company News
06-01-2026
Suven Life Sciences info...
03-11-2025
Suven Life Sciences info...
03-07-2025
Suven Life Sciences infor...
05-06-2025
Suven Life Sciences infor...
13-05-2025
Suven Life Sciences infor...
12-05-2025
Suven Pharmaceuticals inf...
02-04-2025
Suven Life Sciences infor...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.